Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS) SHH

25.30

-0.34(-1.33%)

Updated at December 25 03:00PM

Currency In CNY

Valuation

Market Cap4.29B
Enterprise Value4.35B
P/E Ratio159.74
PEG Ratio23.96
Price/Sales Ratio14.5
Price/Book Ratio10.69
Enterprise/Revenue14.82
Enterprise/EBITDA103.72

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.09
Operating Margin0.11

Management Effectiveness

Return On Assets0.03
Return On Equity0.07

Income Statement

Revenue588.86M
Revenue/Share1.75
Gross Profit559.09M
EBITDA49.57M
Net Income20.76M
Diluted EPS0.05

Balance Sheet

Total Cash217.27M
Total Cash/Share0.54
Total Debt396.68M
Total Debt/Equity0.41
Current Ratio1.52
Book Value Per Share2.39

Price History

52-Week Change127.31
52-Week High34.68
52-Week Low10.07
Moving Average 50 Days24.36
Moving Average 200 Days21.23

Statistics

Average Volume5.83M
Shares Outstanding405.93M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.17
Last Split FactorN/A
Last Split DateN/A